Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 17Novartis Pharmaceuticals Corporation

02 1Novartis South Africa (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

OFATUMUMAB

Brand Name : ARZERRA

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 100MG/5ML

Packaging :

Approval Date :

Application Number : 125326

Regulatory Info :

Registration Country : USA

blank

02

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

OFATUMUMAB

Brand Name : KESIMPTA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 20MG/0.4ML

Packaging :

Approval Date :

Application Number : 125326

Regulatory Info :

Registration Country : USA

blank

03

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumabum

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date : 01/02/2021

Application Number : 67757

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumabum

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date : 01/02/2021

Application Number : 67758

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

06

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Suspension For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 20MG

Packaging :

Approval Date : 10-05-2021

Application Number : 121532003

Regulatory Info : Authorized

Registration Country : Spain

blank

09

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26-03-2021

Application Number : 28106389420

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26-03-2021

Application Number : 28106389520

Regulatory Info : Prescription

Registration Country : Denmark

blank

11

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Arzerra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 19-04-2010

Application Number : 2.01E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

12

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Arzerra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1000mg

Packaging :

Approval Date : 21-02-2011

Application Number : 2.01E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

13

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26-03-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

14

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26-03-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

15

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

OFATUMUMAB

Brand Name : KESIMPTA

Dosage Form : SOLUTION

Dosage Strength : 20MG/0.4ML

Packaging :

Approval Date :

Application Number : 2511355

Regulatory Info : Prescription

Registration Country : Canada

blank

16

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Kesimpta

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

Novartis South Africa (Pty) Ltd

Country
BioProcess International US West
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
BioProcess International US West
Not Confirmed

Ofatumumab

Brand Name : Bonspri

Dosage Form : INJ

Dosage Strength : 20mg

Packaging : 1X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank